About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Philadelphia | 157 Studies

Clinical Trials Alzheimer's DiseasePhiladelphia

Alzheimer's Disease Clinical Trials in Philadelphia

Find 157 clinical trials for alzheimer's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-120 of 157 trials

CompletedOur Care Wishes - DementiaThis Our Care Wishes- Dementia pilot study is adapting an existing successful online advance care planning platform to the specific needs of persons living with dementia and…NCT05033262·Philadelphia, Pennsylvania RecruitingBiofluid Research on Age-Related or Inherited NeurodegenerationThe aim of this study is to contribute to and continue to sustain a repository of blood samples, nucleic acid (DNA and/or RNA) samples, family history information, and other…NCT07798700·Philadelphia, Pennsylvania CompletedStudy to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's DiseaseThis is a multi-center, Phase 1b, randomized, double-blind, placebo-controlled parallel-group trial in adults with mild to moderate AD.NCT03522129·New York, New York and 1 other CompletedAssessing Clinical Outcomes in Alzheimer's Disease AgitationThis is a multi-center, double-blind, placebo-controlled, randomized withdrawal study to evaluate the efficacy and safety of AXS-05 compared to placebo in the treatment of…NCT04797715·Sun City, Arizona and 62 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

CompletedEstrogen Hormone ProtocolEstrogen is a hormone that is dominant in the female reproductive system. In women, most estrogen is produced by the ovaries.NCT00000177·Birmingham, Alabama and 24 others

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient, multiple dose study in male and female patients ages 50 to less than 89 years with mild to…NCT00575055·Birmingham, Alabama and 185 others

CompletedPosiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's PatientsAnnovis is conducting a clinical study to investigate Posiphen in patients with Early Alzheimer's Disease (AD) and Early Parkinson's Disease (PD).NCT04524351·Stamford, Connecticut and 12 others

CompletedAnti-Oxidant Treatment of Alzheimer's DiseaseThe purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease.NCT00117403·Tucson, Arizona and 12 others

TerminatedA Long-Term Safety And Tolerability Extension Study Of Bapineuzumab In Alzheimer Disease PatientsThe purpose of this study is to assess the long-term safety and tolerability of bapineuzumab in subjects with Alzheimer Disease who participated in study 3133K1-3001(NCT00676143).NCT00998764·Birmingham, Alabama and 183 others

TerminatedLiving With Frontotemporal DementiaBackground: \- Frontotemporal dementia (FTD) is the second most common cause of early-onset dementia. Alzheimer s disease is the most common.NCT01738386·Baltimore, Maryland and 2 others

CompletedClinical Evaluation of Florbetapir F 18 (18F-AV-45)This protocol is designed to standardize imaging studies using florbetapir F 18 PET to provide information on amyloid burden in subjects participating in other studies (companion…NCT01518374·Phoenix, Arizona and 25 others

TerminatedEfficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)This randomized, double-blind, placebo-controlled, parallel-group study will evaluate the efficacy and safety of gantenerumab versus placebo in participants with early (prodromal…NCT03444870·Tucson, Arizona and 171 others

CompletedAmyloid Imaging And Safety Study Of Subcutaneous Bapineuzumab In Subjects With Mild to Moderate Alzheimer's DiseaseThis study in individuals with mild to moderate Alzheimer's Disease is designed to assess:(1) safety and tolerability (2) the capacity of subcutaneous bapineuzumab to reduce brain…NCT01254773·Tucson, Arizona and 27 others

TerminatedA Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).This randomized, double-blind, placebo-controlled, parallel group study will evaluate the efficacy and safety of crenezumab versus placebo in participants with prodromal to mild…NCT02670083·Phoenix, Arizona and 195 others

CompletedEffect of Insulin Sensitizer Metformin on AD BiomarkersAlzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of memory and other cognitive functions.NCT01965756·Philadelphia, Pennsylvania

CompletedStudy to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's DiseaseThe study is a 24-week, randomized, double-blind, multi-site, placebo-controlled study in participants with mild cognitive impairment (MCI) or early dementia due to Alzheimer's…NCT03533257·Jacksonville, Florida and 10 others

CompletedA Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)The purpose of this study is to evaluate the ability to identify individuals with dopaminergic degeneration in group of patients with a clinical diagnosis of either dementia with…NCT01503944·Sun City, Arizona and 1 other

TerminatedAcute Effects Of Donepezil On Brain Perfusion And Memory In Subjects With Cognitive Impairment And Mild Alzheimer's DiseaseThe study hypothesizes that donepezil will have a positive impact on brain blood flow deficits in subjects with memory deficits and/or mild dementia and that improvements in brain…NCT01082965·San Francisco, California and 7 others

RecruitingDevelopment of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD DementiaBio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine…NCT06584357·Atlantis, Florida and 25 others

CompletedStudy Evaluating Lecozotan SR in Mild to Moderate Alzheimer's Disease (AD)The purpose of this study is determine the safety, tolerability, and efficacy of 3 doses of lecozotan SR in patients with mild to moderate Alzheimer's Disease over 12 weeks.NCT00151398·Phoenix, Arizona and 55 others

PreviousPage 6 of 8Next

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia